Gil Efron is the Chief Executive Officer of Purple Biotech Ltd., a clinical-stage company dedicated to developing next-generation immunotherapy platforms.
Gil Efron is the Chief Executive Officer of Purple Biotech Ltd., a clinical-stage company dedicated to developing next-generation immunotherapy platforms to combat cancer drug resistance. He leads the organization in advancing lead programs and overseeing the development of novel therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library